In vitro evaluation of dual-antigenic PV1 peptide vaccine in head and neck cancer patients

Peptide vaccines derived from tumour-associated antigens have been used as an immunotherapeutic approach to induce specific cytotoxic immune response against tumour. We previously identified that MAGED4B and FJX1 proteins are overexpressed in HNSCC patients; and further demonstrated that two HLA-A2-...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hum Vaccin Immunother
Auteurs principaux: Chai, San Jiun, Fong, Sammuel Chee Yong, Gan, Chai Phei, Pua, Kin Choo, Lim, Paul Vey Hong, Lau, Shin Hin, Zain, Rosnah Binti, Abraham, Thomas, Ismail, Siti Mazlipah, Abdul Rahman, Zainal Ariff, Ponniah, Sathibalan, Patel, Vyomesh, Cheong, Sok Ching, Lim, Kue Peng
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2018
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6363157/
https://ncbi.nlm.nih.gov/pubmed/30193086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1520584
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires